StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Biggaineron Jun 05, 2020 4:14pm

94 Views

Post# 31118275

RE:RE:Market Rebound

According to W.H.O?

2016 data:

Ischaemic heart disease and stroke are the world’s biggest killers, accounting for a combined 15.2 million deaths.

Lower respiratory infections remained the most deadly communicable disease, causing 3.0 million deaths.

Even death rate from diarrhoeal diseases caused 1.4 million deaths.

That reminds me, I'll be right back.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"